ATO/ATRA/anthracycline-chemotherapy sequential consolidation achieves long-term efficacy in primary acute promyelocytic leukemia.

ATO/ATRA/anthracycline-chemotherapy sequential consolidation achieves long-term efficacy in primary acute promyelocytic leukemia.

The combination of all-trans retinoic acid (ATRA) and arsenic trioxide (As2O3, ATO) has been effective in obtaining high clinical complete remission (CR) rates in acute promyelocytic leukemia (APL), but the long-term efficacy and safety among newly diagnosed APL patients are unclear. In this retrosp...

Full description

Bibliographic Details
Main Authors: Zi-Jie Long, Yuan Hu, Xu-Dong Li, Yi He, Ruo-Zhi Xiao, Zhi-Gang Fang, Dong-Ning Wang, Jia-Jun Liu, Jin-Song Yan, Ren-Wei Huang, Dong-Jun Lin, Quentin Liu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4133252?pdf=render

Internet

http://europepmc.org/articles/PMC4133252?pdf=render

Similar Items